GARIMA CHAUHAN

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• A Pharmacological Overview and Recent Patent of Triazine Scaffold in Drug Development: A Review
  Current Organic Synthesis 2025 DOI: 10.2174/0115701794272212240307092318
  +Save
• 1,3,5 and 1,2,4-triazines as Potent Scaffolds for Molecules Potentially Attenuating Breast Cancer Cell Lines
  Current Organic Chemistry 2023 DOI: 10.2174/1385272827666230215141854
  +Save
• Current Advancement in the Oxadiazole-Based Scaffolds as Anticancer Agents
  Polycyclic Aromatic Compounds 2022 DOI: 10.1080/10406638.2021.1886123
  +Save
• In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review
  Anti-Cancer Agents in Medicinal Chemistry 2022 DOI: 10.2174/1871520621666210903130152
  +Save
• Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers
  Archives of Pharmacal Research 2022 DOI: 10.1007/s12272-022-01385-3
  +Save
• Dihydropyrimidinones Scaffold as a Promising Nucleus for Synthetic Profile and Various Therapeutic Targets: A Review
  Current Organic Synthesis 2021 DOI: 10.2174/1570179417666201207215710
  +Save
• Advances in Synthesis, Derivatization and Bioactivity of Isatin: A Review
  Current Organic Synthesis 2021 DOI: 10.2174/1570179417666200924150907
  +Save
• DABCO-catalyzed synthesis of 3-substituted-3-hydroxyindolin-2-ones in aqueous media
  Synthetic Communications 2016 DOI: 10.1080/00397911.2016.1160411
  +Save